IONS vs GDDY Comparison

Ionis Pharmaceuticals is the leading developer of antisense technology to discover and develop novel drugs. Its broad clinical and preclinical pipeline targets a wide variety of diseases, with an emphasis on cardiovascular, metabolic, neurological, and rare diseases. Ionis and Biogen brought Spinraza to market in 2016 as a treatment for spinal muscular atrophy, and Biogen launched ALS drug Qalsody in 2023. Ionis brought two additional drugs to market via its cardiovascular-focused subsidiary Akcea, including ATTR amyloidosis drug Tegsedi (2018) and cardiology drug Waylivra (Europe, 2019). Ionis and AstraZeneca launched polyneuropathy drug Wainua in 2024. Ionis received FDA approval in 2024 for Tryngolza for a rare high-triglyceride syndrome, marking its first independent launch.

GoDaddy provides a comprehensive portfolio of solutions to help entrepreneurs manage their company's digital presence. In particular, GoDaddy helps customers establish websites, attract customers, and generate revenue. It operates through two segments—the core platform and applications and commerce. The core platform consists of domain registration services as well as hosting and security services. The newer applications and commerce segment consists of website design, marketing tools, and payment services. As of fiscal 2024, the company had over 20,000 customers and greater than 80 million domains under management.